Valuation: Sinocare Inc.

Market Cap 8.09B 1.21B 1.04B 984M 892M 1.67B 115B 1.68B 11.69B 4.5B 58.65B 4.53B 4.43B 185B P/E 2026 *
21.5x
P/E 2027 * 17.9x
Enterprise Value 8.09B 1.21B 1.04B 984M 892M 1.67B 115B 1.68B 11.69B 4.5B 58.65B 4.53B 4.43B 185B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.46x
Free-Float
50.69%
Yield 2026 *
1.48%
Yield 2027 * 1.65%
1 day-1.94%
1 week-5.18%
Current month-4.89%
1 month-8.28%
3 months+2.57%
6 months-10.07%
Current year-11.28%
1 week 15.1
Extreme 15.1
15.99
1 month 15.1
Extreme 15.1
16.6
Current year 13.37
Extreme 13.37
20.32
1 year 13.37
Extreme 13.37
20.88
3 years 13.37
Extreme 13.37
35.46
5 years 13.3
Extreme 13.3
39.21
10 years 9.62
Extreme 9.62
53.69
Manager TitleAgeSince
Chief Executive Officer 36 2025-12-30
Director of Finance/CFO 52 2023-12-28
Compliance Officer 42 2016-01-31
Director TitleAgeSince
Chairman 61 2010-12-02
Director/Board Member 53 2015-09-24
Director/Board Member 42 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
1/30/26 Buy

Chief Executive Officer

571,800 0.1256%
3/16/25 Buy 62,600 0.0137%
1/12/21 Sell

Chairman

11,600 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.94%-5.18%-27.09%-38.74% 1.21B
-1.36%-5.89%-23.76%-0.72% 176B
-0.72%-3.41%-3.26%+11.85% 116B
+0.19%-2.83%+6.30%+82.00% 61.36B
-1.15%-7.10%+3.53%+37.10% 49.42B
+0.81%-3.73%-4.81%-32.89% 48.44B
-1.75%-5.54%+8.93%-21.09% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.41% 24.37B
+0.73%-4.68%-10.24%+4.31% 21.57B
Average -0.20%-4.82%-1.54%+3.27% 55.9B
Weighted average by Cap. -0.04%-4.83%-6.27%+10.57%

Financials

2026 *2027 *
Net sales 5.06B 754M 650M 615M 558M 1.05B 72.05B 1.05B 7.31B 2.81B 36.66B 2.83B 2.77B 116B 5.56B 829M 714M 676M 613M 1.15B 79.17B 1.16B 8.03B 3.09B 40.28B 3.11B 3.04B 127B
Net income 395M 58.82M 50.68M 47.99M 43.5M 81.6M 5.62B 82.01M 570M 219M 2.86B 221M 216M 9.03B 472M 70.29M 60.56M 57.35M 51.98M 97.51M 6.72B 98.01M 681M 262M 3.42B 264M 258M 10.8B
Net Debt - -
Logo Sinocare Inc.
Sinocare Inc is a China-based company primarily engaged in providing chronic disease testing products and health management services to chronic disease patients and medical institutions. The Company’s main products include blood glucose monitoring systems, diabetes nutrition and nursing support products, lipid profile monitoring systems, intelligent point-of-care (iPOCT) monitoring systems, glycated hemoglobin testing systems, blood pressure monitors and others. The Company is also engaged in providing systematic chronic disease assessments, standardized treatments, comprehensive in-hospital and out-of-hospital health management, knowledge education, and psychological counseling services to patients with metabolic diseases such as diabetes, obesity, and hyperuricemia. The Company conducts its business in the domestic and overseas markets.
Employees
4,994
Date Price Change Volume
26-09-11 CN¥15.18 -1.94% 3,183,473
26-09-10 CN¥15.48 -0.45% 2,576,336
26-09-09 CN¥15.55 -2.20% 3,459,907
26-09-08 CN¥15.90 +0.70% 2,983,500
26-09-07 CN¥15.79 -1.37% 3,933,400
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.18CNY
Average target price
22.88CNY
Spread / Average Target
+50.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300298 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!